Related Experiment Videos
Hypoglycemia in hypopituitary children
Insights
Growth hormone (GH) deficiency in children can lead to hypoglycemia. Young, lean children with GH deficiency are more prone to symptomatic hypoglycemia, which improves with human growth hormone (HGH) therapy.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Hormone Therapy
Background:
- Growth hormone (GH) deficiency is a condition affecting childhood development.
- Hypoglycemia, or low blood sugar, is a potential complication in children with pituitary deficiencies.
- Understanding factors influencing hypoglycemia is crucial for managing these patients.
Purpose of the Study:
- To identify factors contributing to hypoglycemia in children with GH deficiency.
- To investigate the relationship between hypoglycemia and the severity of pituitary dysfunction.
- To assess the impact of human growth hormone (HGH) therapy on hypoglycemia and related metabolic parameters.
Main Methods:
- Retrospective analysis of 52 children diagnosed with GH deficiency.
- Categorization of hypoglycemia into symptomatic and asymptomatic forms.
- Evaluation of anthropometric data, including height age/weight age (HA/WA) ratio.
- Assessment of insulin response to oral glucose and intravenous arginine challenges.
- Monitoring of HA/WA ratios and carbohydrate homeostasis during HGH therapy.
Main Results:
- Hypoglycemia occurred in 17% (symptomatic) and 27% (asymptomatic) of children.
- Symptomatic hypoglycemia was more prevalent in younger (under 4 years) and leaner children (elevated HA/WA ratio).
- HGH therapy led to reduced HA/WA ratios and improved carbohydrate metabolism.
- Children with symptomatic hypoglycemia exhibited diminished insulin responses to glucose and arginine.
Conclusions:
- Young, lean children with GH deficiency are at higher risk for symptomatic hypoglycemia.
- Impaired gluconeogenic substrate or amino acid mobilization may contribute to hypoglycemia in hypopituitarism.
- HGH therapy can improve metabolic control and reduce hypoglycemia risk in affected children.
Abstract:
Fifty-two children with growth hormone (GH) deficiency were examined for factors that might influence development of hypoglycemia. Symptomatic and asymptomatic hypoglycemia occurred with equal frequency in children with isolated GH and multiple anterior pituitary deficiencies. Of 52 children, nine (17%) had symptomatic hypoglycemia and 14 (27%) had asymptomatic hypoglycemia. Symptomatic hypoglycemia was more frequent in children who were both young (less than 4 years of age) and lean (elevated height age/weight age [HA/WA] ratio). With HGH therapy, these children had decreases in HA/WA ratios and improvement in carbohydrate homeostasis. Insulin responses to oral glucose and intravenous arginine administration were substantially lowered in children with symptomatic hypoglycemia, A deficiency of gluconeogenic substrate or impairment of amino acid mobilization may be a factor in the development of hypoglycemia in hypopituitarism similar to that postulated for ketotic hypoglycemia.